PROMETHEUS BIOSCIENCES, INC. Proceeds from Common Stock Issued
PROMETHEUS BIOSCIENCES, INC. reported Proceeds from Common Stock Issued of $53.16 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $53.16M.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $501.12M.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $73.11M.
- PROMETHEUS BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2022 was $589.39M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-03-31 | $53.16M 10-Q · filed 2023-05-09 | $554.27M derived: sum of 2 quarters · filed 2023-05-09 | $627.39M derived: sum of 3 quarters · filed 2023-05-09 | |
| 2022-12-31 | $501.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $574.23M derived: sum of 2 quarters · filed 2023-02-28 | $589.39M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $73.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $88.28M 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $15.16M 10-Q · filed 2022-08-11 |